Skip Navigation
Genetics Home Reference: your guide to understanding genetic conditions
http://ghr.nlm.nih.gov/     A service of the U.S. National Library of Medicine®

X-linked lymphoproliferative disease

(often shortened to XLP)
Reviewed November 2014

What is XLP?

X-linked lymphoproliferative disease (XLP) is a disorder of the immune system and blood-forming cells that is found almost exclusively in males. More than half of individuals with this disorder experience an exaggerated immune response to the Epstein-Barr virus (EBV). EBV is a very common virus that eventually infects most humans. In some people it causes infectious mononucleosis (commonly known as "mono"). Normally, after initial infection, EBV remains in certain immune system cells (lymphocytes) called B cells. However, the virus is generally inactive (latent) because it is controlled by other lymphocytes called T cells that specifically target EBV-infected B cells.

People with XLP may respond to EBV infection by producing abnormally large numbers of T cells, B cells, and other lymphocytes called macrophages. This proliferation of immune cells often causes a life-threatening reaction called hemophagocytic lymphohistiocytosis. Hemophagocytic lymphohistiocytosis causes fever, destroys blood-producing cells in the bone marrow, and damages the liver. The spleen, heart, kidneys, and other organs and tissues may also be affected. In some individuals with XLP, hemophagocytic lymphohistiocytosis or related symptoms may occur without EBV infection.

About one-third of people with XLP experience dysgammaglobulinemia, which means they have abnormal levels of some types of antibodies. Antibodies (also known as immunoglobulins) are proteins that attach to specific foreign particles and germs, marking them for destruction. Individuals with dysgammaglobulinemia are prone to recurrent infections.

Cancers of immune system cells (lymphomas) occur in about one-third of people with XLP.

Without treatment, most people with XLP survive only into childhood. Death usually results from hemophagocytic lymphohistiocytosis.

XLP can be divided into two types based on its genetic cause and pattern of signs and symptoms: XLP1 (also known as classic XLP) and XLP2. People with XLP2 have not been known to develop lymphoma, are more likely to develop hemophagocytic lymphohistiocytosis without EBV infection, usually have an enlarged spleen (splenomegaly), and may also have inflammation of the large intestine (colitis). Some researchers believe that these individuals should actually be considered to have a similar but separate disorder rather than a type of XLP.

How common is XLP?

XLP1 is estimated to occur in about 1 per million males worldwide. XLP2 is less common, occurring in about 1 per 5 million males.

What genes are related to XLP?

Mutations in the SH2D1A and XIAP genes cause XLP. SH2D1A gene mutations cause XLP1, and XIAP gene mutations cause XLP2.

The SH2D1A gene provides instructions for making a protein called signaling lymphocyte activation molecule (SLAM) associated protein (SAP). This protein is involved in the functioning of lymphocytes that destroy other cells (cytotoxic lymphocytes) and is necessary for the development of specialized T cells called natural killer T cells. The SAP protein also helps control immune reactions by triggering self-destruction (apoptosis) of cytotoxic lymphocytes when they are no longer needed.

Some SH2D1A gene mutations impair SAP function. Others result in an abnormally short protein that is unstable or nonfunctional, or prevent any SAP from being produced. The loss of functional SAP disrupts proper signaling in the immune system and may prevent the body from controlling the immune reaction to EBV infection. In addition, lymphomas may develop when defective lymphocytes are not properly destroyed by apoptosis.

The XIAP gene provides instructions for making a protein that helps protect cells from undergoing apoptosis in response to certain signals. XIAP gene mutations can lead to an absence of XIAP protein or decrease the amount of XIAP protein that is produced. It is unknown how a lack of XIAP protein results in the signs and symptoms of XLP, or why features of this disorder differ somewhat between people with XIAP and SH2D1A gene mutations.

Related Gene(s)

Changes in these genes are associated with X-linked lymphoproliferative disease.

  • SH2D1A
  • XIAP

How do people inherit XLP?

This condition is generally inherited in an X-linked recessive pattern. The genes associated with this condition are located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of an associated gene in each cell is sufficient to cause the condition. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

In females (who have two X chromosomes), a mutation usually has to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of an associated gene, males are affected by X-linked recessive disorders much more frequently than females. However, in rare cases a female carrying one altered copy of the SH2D1A or XIAP gene in each cell may develop signs and symptoms of this condition.

Where can I find information about diagnosis or management of XLP?

These resources address the diagnosis or management of XLP and may include treatment providers.

  • Children's Hospital of Philadelphia (http://www.chop.edu/conditions-diseases/x-linked-lymphoproliferative-syndrome)
  • Gene Review: Lymphoproliferative Disease, X-Linked (http://www.ncbi.nlm.nih.gov/books/NBK1406)
  • Genetic Testing Registry: X-linked lymphoproliferative syndrome 1 (http://www.ncbi.nlm.nih.gov/gtr/conditions/C1868674)
  • Genetic Testing Registry: X-linked lymphoproliferative syndrome 2 (http://www.ncbi.nlm.nih.gov/gtr/conditions/C1845076)
  • MedlinePlus Encyclopedia: Epstein-Barr Virus Test (http://www.nlm.nih.gov/medlineplus/ency/article/003513.htm)
  • Merck Manual for Healthcare Professionals (http://www.merckmanuals.com/professional/immunology_allergic_disorders/immunodeficiency_disorders/x-linked_lymphoproliferative_syndrome.html)
  • XLP Research Trust: Immunoglobulin Replacement (http://www.xlpresearchtrust.org/download.asp?File=XLPRT_Immunoglobulin_July08)
  • XLP Research Trust: Preparing for Bone Marrow Transplant (http://www.xlpresearchtrust.org/download.asp?File=XLPRT_BMT_August08)

You might also find information on the diagnosis or management of XLP in Educational resources (http://www.ghr.nlm.nih.gov/condition/x-linked-lymphoproliferative-disease/show/Educational+resources) and Patient support (http://www.ghr.nlm.nih.gov/condition/x-linked-lymphoproliferative-disease/show/Patient+support).

General information about the diagnosis (http://ghr.nlm.nih.gov/handbook/consult/diagnosis) and management (http://ghr.nlm.nih.gov/handbook/consult/treatment) of genetic conditions is available in the Handbook. Read more about genetic testing (http://ghr.nlm.nih.gov/handbook/testing), particularly the difference between clinical tests and research tests (http://ghr.nlm.nih.gov/handbook/testing/researchtesting).

To locate a healthcare provider, see How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.

Where can I find additional information about XLP?

You may find the following resources about XLP helpful. These materials are written for the general public.

You may also be interested in these resources, which are designed for healthcare professionals and researchers.

What other names do people use for XLP?

  • Duncan disease
  • Epstein-Barr virus-induced lymphoproliferative disease in males
  • familial fatal Epstein-Barr infection
  • Purtilo syndrome
  • severe susceptibility to EBV infection
  • severe susceptibility to infectious mononucleosis
  • X-linked lymphoproliferative syndrome

For more information about naming genetic conditions, see the Genetics Home Reference Condition Naming Guidelines (http://ghr.nlm.nih.gov/ConditionNameGuide) and How are genetic conditions and genes named? (http://ghr.nlm.nih.gov/handbook/mutationsanddisorders/naming) in the Handbook.

What if I still have specific questions about XLP?

Ask the Genetic and Rare Diseases Information Center (http://rarediseases.info.nih.gov/GARD/).

What glossary definitions help with understanding XLP?

apoptosis ; bone marrow ; cell ; chromosome ; colitis ; enlarged spleen ; familial ; fever ; gene ; immune response ; immune system ; infection ; inflammation ; inheritance ; inherited ; intestine ; lymphocyte ; lymphoma ; molecule ; mutation ; proliferation ; protein ; recessive ; sex chromosomes ; splenomegaly ; susceptibility ; syndrome ; virus ; X-linked recessive

You may find definitions for these and many other terms in the Genetics Home Reference Glossary (http://www.ghr.nlm.nih.gov/glossary).

References

  • Bassiri H, Janice Yeo WC, Rothman J, Koretzky GA, Nichols KE. X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses. Immunol Res. 2008;42(1-3):145-59. doi: 10.1007/s12026-008-8048-7. Review. (http://www.ncbi.nlm.nih.gov/pubmed/18815745?dopt=Abstract)
  • Gene Review: Lymphoproliferative Disease, X-Linked (http://www.ncbi.nlm.nih.gov/books/NBK1406)
  • Latour S. Natural killer T cells and X-linked lymphoproliferative syndrome. Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):510-4. Review. (http://www.ncbi.nlm.nih.gov/pubmed/17989527?dopt=Abstract)
  • Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, Bleesing JJ, Zhang K, Filipovich AH. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010 Aug 19;116(7):1079-82. doi: 10.1182/blood-2010-01-256099. Epub 2010 May 20. (http://www.ncbi.nlm.nih.gov/pubmed/20489057?dopt=Abstract)
  • Marsh RA, Villanueva J, Kim MO, Zhang K, Marmer D, Risma KA, Jordan MB, Bleesing JJ, Filipovich AH. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin Immunol. 2009 Jul;132(1):116-23. doi: 10.1016/j.clim.2009.03.517. Epub 2009 Apr 23. (http://www.ncbi.nlm.nih.gov/pubmed/19398375?dopt=Abstract)
  • Nagy N, Klein E. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development. Immunol Lett. 2010 May 4;130(1-2):13-8. doi: 10.1016/j.imlet.2010.01.002. Epub 2010 Jan 18. Review. (http://www.ncbi.nlm.nih.gov/pubmed/20080127?dopt=Abstract)
  • Nagy N, Matskova L, Hellman U, Klein G, Klein E. The apoptosis modulating role of SAP (SLAM associated protein) contributes to the symptomatology of the X linked lymphoproliferative disease. Cell Cycle. 2009 Oct 1;8(19):3086-90. Epub 2009 Oct 27. (http://www.ncbi.nlm.nih.gov/pubmed/19738428?dopt=Abstract)
  • Rigaud S, Fondanèche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006 Nov 2;444(7115):110-4. (http://www.ncbi.nlm.nih.gov/pubmed/17080092?dopt=Abstract)
  • Schuster V, Kreth HW. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein. Immunol Rev. 2000 Dec;178:21-8. Review. (http://www.ncbi.nlm.nih.gov/pubmed/11213803?dopt=Abstract)
  • Snow AL, Marsh RA, Krummey SM, Roehrs P, Young LR, Zhang K, van Hoff J, Dhar D, Nichols KE, Filipovich AH, Su HC, Bleesing JJ, Lenardo MJ. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. J Clin Invest. 2009 Oct;119(10):2976-89. doi: 10.1172/JCI39518. Epub 2009 Sep 14. (http://www.ncbi.nlm.nih.gov/pubmed/19759517?dopt=Abstract)
  • Woon ST, Ameratunga R, Croxson M, Taylor G, Neas K, Edkins E, Browett P, Gane E, Munn S. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female. Scand J Immunol. 2008 Aug;68(2):153-8. doi: 10.1111/j.1365-3083.2008.02128.x. Erratum in: Scand J Immunol. 2008 Sep;68(3):362. (http://www.ncbi.nlm.nih.gov/pubmed/18702745?dopt=Abstract)

 

The resources on this site should not be used as a substitute for professional medical care or advice. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional. See How can I find a genetics professional in my area? (http://ghr.nlm.nih.gov/handbook/consult/findingprofessional) in the Handbook.

 
Reviewed: November 2014
Published: December 22, 2014